19 Aug Is Sanofi A Buy, Despite Recent Stumbles? Posted at 05:00h in Popular Newsfeed by RJW™ 0 Comments 0 Likes Share Pharmaceuticals are subject to whiplash trade. That’s evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions. Source: Entrepreneur.com Lastest News Tags: Entrepreneurship
Sorry, the comment form is closed at this time.